Skip to content

Author

Charles Jiang

We have 1 of 14 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Accrual speed and characteristics of phase III U.S. cancer clinical trials with frequently used biomarkers in eligibility criteria.

475 Background: Patient accrual remains a key rate-limiting step in cancer clinical trials, often influencing statistical power, trial budgets, and delayed access to therapies. In particular, trials involving biomarker measurement may have accrual concerns related to the additional screening procedures in suppo...

Fang-Yuan Chen, R. Nipp, Bo-Shen Jiao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.